Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Tomasec

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Journal of General Virology|May 19, 2010
Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell cultureDerrick J Dargan, Elaine Douglas, Charles Cunningham, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 11, 2007
Modulation of natural killer cells by human cytomegalovirusGavin W G Wilkinson, Peter Tomasec, Richard J Stanton, et al.
Plos Pathogens|April 16, 2015
Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141Jye-Lin Hsu, Dick J H van den Boomen, Peter Tomasec, et al.
Journal of Virology|February 22, 2008
Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and BBrian P McSharry, Hans-Gerhard Burgert, Douglas P Owen, et al.
Cell Host & Microbe|March 19, 2013
Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defensesWendell Smith, Peter Tomasec, Rebecca Aicheler, et al.
Plos Pathogens|May 3, 2014
Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradationCeri A Fielding, Rebecca Aicheler, Richard J Stanton, et al.
Cell Host & Microbe|August 15, 2014
HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cellsRichard J Stanton, Virginie Prod'homme, Marco A Purbhoo, et al.
Elife|February 11, 2017
Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activationCeri A Fielding, Michael P Weekes, Luis V Nobre, et al.
Cell Host & Microbe|August 21, 2018
High-Definition Analysis of Host Protein Stability during Human Cytomegalovirus Infection Reveals Antiviral Factors and Viral Evasion MechanismsKatie Nightingale, Kai-Min Lin, Benjamin J Ravenhill, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2023
ADAM17 targeting by human cytomegalovirus remodels the cell surface proteome to simultaneously regulate multiple immune pathwaysAnzelika Rubina, Mihil Patel, Katie Nightingale, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Journal of General Virology|May 19, 2010
Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell cultureDerrick J Dargan, Elaine Douglas, Charles Cunningham, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 11, 2007
Modulation of natural killer cells by human cytomegalovirusGavin W G Wilkinson, Peter Tomasec, Richard J Stanton, et al.
Plos Pathogens|April 16, 2015
Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141Jye-Lin Hsu, Dick J H van den Boomen, Peter Tomasec, et al.
Journal of Virology|February 22, 2008
Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and BBrian P McSharry, Hans-Gerhard Burgert, Douglas P Owen, et al.
Cell Host & Microbe|March 19, 2013
Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defensesWendell Smith, Peter Tomasec, Rebecca Aicheler, et al.
Plos Pathogens|May 3, 2014
Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradationCeri A Fielding, Rebecca Aicheler, Richard J Stanton, et al.
Cell Host & Microbe|August 15, 2014
HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cellsRichard J Stanton, Virginie Prod'homme, Marco A Purbhoo, et al.
Elife|February 11, 2017
Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activationCeri A Fielding, Michael P Weekes, Luis V Nobre, et al.
Cell Host & Microbe|August 21, 2018
High-Definition Analysis of Host Protein Stability during Human Cytomegalovirus Infection Reveals Antiviral Factors and Viral Evasion MechanismsKatie Nightingale, Kai-Min Lin, Benjamin J Ravenhill, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2023
ADAM17 targeting by human cytomegalovirus remodels the cell surface proteome to simultaneously regulate multiple immune pathwaysAnzelika Rubina, Mihil Patel, Katie Nightingale, et al.
Pageof 4